# Filing Detail

Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001140361-24-042487
Filing Date
2024-10-01
Accepted
2024-10-01 16:36:47
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B7 | ny20033174x7_424b7.htm | 424B7 | 5670072
2 |  | logo_cartesian.jpg | GRAPHIC | 51818
3 |  | logo_cartesianx1.jpg | GRAPHIC | 58064
4 |  | ny20033174x7_diagram01.jpg | GRAPHIC | 238752
5 |  | ny20033174x7_diagram02.jpg | GRAPHIC | 123565
6 |  | ny20033174x7_diagram03.jpg | GRAPHIC | 155500
7 |  | ny20033174x7_linecharts01.jpg | GRAPHIC | 300512
8 |  | ny20033174x7_linecharts02.jpg | GRAPHIC | 219493
9 |  | ny20033174x7_safety.jpg | GRAPHIC | 519606
| Complete submission text file | 0001140361-24-042487.txt |  | 7965936

Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-281204 | Film No.: 241343867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)